153 related articles for article (PubMed ID: 8019453)
1. Comparison of engraftment in recipients of matched sibling of unrelated donor marrow allografts.
Davies SM; Ramsay NK; Haake RJ; Kersey JH; Weisdorf DJ; McGlave PB; Blazar BR
Bone Marrow Transplant; 1994 Jan; 13(1):51-7. PubMed ID: 8019453
[TBL] [Abstract][Full Text] [Related]
2. Comparison of matched-sibling donor BMT and unrelated donor BMT in children and adolescent with acquired severe aplastic anemia.
Yagasaki H; Takahashi Y; Hama A; Kudo K; Nishio N; Muramatsu H; Tanaka M; Yoshida N; Matsumoto K; Watanabe N; Kato K; Horibe K; Kojima S
Bone Marrow Transplant; 2010 Oct; 45(10):1508-13. PubMed ID: 20118992
[TBL] [Abstract][Full Text] [Related]
3. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
4. Equivalent survival for sibling and unrelated donor allogeneic stem cell transplantation for acute myelogenous leukemia.
Moore J; Nivison-Smith I; Goh K; Ma D; Bradstock K; Szer J; Durrant S; Schwarer A; Bardy P; Herrmann R; Dodds A
Biol Blood Marrow Transplant; 2007 May; 13(5):601-7. PubMed ID: 17448920
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow engraftment following unrelated donor transplantation utilizing busulfan and cyclophosphamide preparatory chemotherapy.
Klein JL; Avalos BR; Belt P; Taylor CA; Ezzone SA; Scholl MD; Fisher J; Young D; Copelan EA
Bone Marrow Transplant; 1996 Apr; 17(4):479-83. PubMed ID: 8722342
[TBL] [Abstract][Full Text] [Related]
6. Analysis of 500 bone marrow transplants from unrelated donors (UR-BMT) facilitated by the Japan Marrow Donor Program: confirmation of UR-BMT as a standard therapy for patients with leukemia and aplastic anemia.
Kodera Y; Morishima Y; Kato S; Akiyama Y; Sao H; Matsuyama T; Kawa K; Sakamaki H; Nakagawa S; Hirabayashi N; Dohi H; Okamoto S; Hiraoka A; Gondo H; Tsuchida M; O H; Harada M; Asano S; Juji T; Sasazuki T; Takaku F
Bone Marrow Transplant; 1999 Nov; 24(9):995-1003. PubMed ID: 10556959
[TBL] [Abstract][Full Text] [Related]
7. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.
Keever-Taylor CA; Bredeson C; Loberiza FR; Casper JT; Lawton C; Rizzo D; Burns WH; Margolis DA; Vesole DH; Horowitz M; Zhang MJ; Juckett M; Drobyski WR
Biol Blood Marrow Transplant; 2001; 7(11):620-30. PubMed ID: 11760150
[TBL] [Abstract][Full Text] [Related]
8. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program.
Kernan NA; Bartsch G; Ash RC; Beatty PG; Champlin R; Filipovich A; Gajewski J; Hansen JA; Henslee-Downey J; McCullough J
N Engl J Med; 1993 Mar; 328(9):593-602. PubMed ID: 8429851
[TBL] [Abstract][Full Text] [Related]
9. European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Devergie A; Apperley JF; Labopin M; Madrigal A; Jacobsen N; Carreras E; Prentice HG; Jouet JP; Kolb HJ; Herstenstein B; Bacigalupo A; Evensen SA; Ljungman P; de Witte T; Reiffers J; Nagler A; Clark RE; Goldman JM; Gratwohl A
Bone Marrow Transplant; 1997 Jul; 20(1):11-9. PubMed ID: 9232250
[TBL] [Abstract][Full Text] [Related]
10. Single-centre experience with allogeneic bone marrow transplantation for acute lymphoblastic leukaemia in childhood: similar survival after matched-related and matched-unrelated donor transplants.
Al-Kasim FA; Thornley I; Rolland M; Lau W; Tsang R; Freedman MH; Saunders EF; Calderwood S; Doyle JJ
Br J Haematol; 2002 Feb; 116(2):483-90. PubMed ID: 11841456
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow transplantation using unrelated and family related donors: the impact of HLA-C disparity.
Nagler A; Brautbar C; Slavin S; Bishara A
Bone Marrow Transplant; 1996 Nov; 18(5):891-7. PubMed ID: 8932842
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of transplantation with partial T-cell depletion of matched or mismatched unrelated or partially matched related donor bone marrow in children and adolescents with leukemias.
Bunin N; Aplenc R; Leahey A; Magira E; Grupp S; Pierson G; Monos D
Bone Marrow Transplant; 2005 Jan; 35(2):151-8. PubMed ID: 15531896
[TBL] [Abstract][Full Text] [Related]
13. Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population.
Schönberger S; Niehues T; Meisel R; Bernbeck B; Laws HJ; Kögler G; Enzmann J; Wernet P; Göbel U; Dilloo D
Klin Padiatr; 2004; 216(6):356-63. PubMed ID: 15565551
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia.
Passweg JR; Pérez WS; Eapen M; Camitta BM; Gluckman E; Hinterberger W; Hows JM; Marsh JC; Pasquini R; Schrezenmeier H; Socié G; Zhang MJ; Bredeson C
Bone Marrow Transplant; 2006 Apr; 37(7):641-9. PubMed ID: 16489361
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the outcomes of allogeneic bone marrow transplantation from partially mismatched related donors, matched sibling donors, and matched unrelated donors in Japanese pediatric patients: a single center result.
Nagatoshi Y; Kawano Y; Okamura J
Pediatr Transplant; 2004 Jun; 8(3):260-6. PubMed ID: 15176964
[TBL] [Abstract][Full Text] [Related]
16. Short-term toxicity in pediatric marrow transplantation using related and unrelated donors.
Vettenranta K; Hovi L; Saarinen-Pihkala UM
Bone Marrow Transplant; 1999 Mar; 23(5):459-62. PubMed ID: 10100559
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic bone marrow transplantation for chronic myelogenous leukemia: comparative analysis of unrelated versus matched sibling donor transplantation.
Weisdorf DJ; Anasetti C; Antin JH; Kernan NA; Kollman C; Snyder D; Petersdorf E; Nelson G; McGlave P
Blood; 2002 Mar; 99(6):1971-7. PubMed ID: 11877268
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
[TBL] [Abstract][Full Text] [Related]
19. The use of unrelated donors (UD) for allogeneic bone marrow transplantation (BMT): a pilot study of the Canadian BMT Group.
Phillips GL
Bone Marrow Transplant; 1991; 7 Suppl 1():52-3. PubMed ID: 2043887
[TBL] [Abstract][Full Text] [Related]
20. Comparison of long-term outcomes after allogeneic hematopoietic stem cell transplantation from matched sibling and unrelated donors.
Hows JM; Passweg JR; Tichelli A; Locasciulli A; Szydlo R; Bacigalupo A; Jacobson N; Ljungman P; Cornish J; Nunn A; Bradley B; Socié G; ;
Bone Marrow Transplant; 2006 Dec; 38(12):799-805. PubMed ID: 17075568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
